• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence.

作者信息

Cohen Myron S

机构信息

From the Institute for Global Heath and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill.

出版信息

N Engl J Med. 2020 Aug 6;383(6):585-586. doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.

DOI:10.1056/NEJMe2020388
PMID:32492298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7289275/
Abstract
摘要

相似文献

1
Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence.羟氯喹预防新型冠状病毒肺炎——寻找证据
N Engl J Med. 2020 Aug 6;383(6):585-586. doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.
2
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.氯喹或羟氯喹用于预防2019冠状病毒病。
Lancet Infect Dis. 2020 Oct;20(10):1118. doi: 10.1016/S1473-3099(20)30296-6. Epub 2020 Apr 17.
3
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?羟氯喹啉和伊维菌素：用于新冠病毒化学预防和治疗的协同组合？
J Am Acad Dermatol. 2020 Jun;82(6):e221. doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10.
4
Hydroxychloroquine prophylaxis for COVID-19 contacts in India.印度针对新冠病毒病接触者的羟氯喹预防措施
Lancet Infect Dis. 2020 Oct;20(10):1118-1119. doi: 10.1016/S1473-3099(20)30313-3. Epub 2020 Apr 17.
5
Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis.用于 COVID-19 预防的羟氯喹引起的肌无力综合征。
J Clin Neuromuscul Dis. 2020 Sep;22(1):60-62. doi: 10.1097/CND.0000000000000316.
6
Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.COVID-19大流行期间的紧急使用授权：羟氯喹用于疫苗授权和批准的经验教训。
JAMA. 2020 Oct 6;324(13):1282-1283. doi: 10.1001/jama.2020.16253.
7
Internet Searches for Unproven COVID-19 Therapies in the United States.互联网上对未经证实的新冠病毒治疗方法的搜索情况。
JAMA Intern Med. 2020 Aug 1;180(8):1116-1118. doi: 10.1001/jamainternmed.2020.1764.
8
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.羟氯喹在预防新型冠状病毒感染方面的争议使风湿病学家站在了前沿。
RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001323.
9
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
10
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.揭示羟氯喹在新型冠状病毒肺炎中的证据
Crit Care. 2020 Apr 28;24(1):182. doi: 10.1186/s13054-020-02894-7.

引用本文的文献

1
Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19.间充质干细胞及其分离的外泌体对缓解由COVID-19引起的急性呼吸窘迫综合征的潜在治疗作用及纳米递送系统
Regen Ther. 2024 Apr 16;27:319-328. doi: 10.1016/j.reth.2024.03.015. eCollection 2024 Dec.
2
Personal rights over public Health: Anti-vaccine rhetoric in the Texas Legislature.公共卫生领域的个人权利：德克萨斯州立法机构中的反疫苗言论
Vaccine X. 2024 Feb 28;18:100468. doi: 10.1016/j.jvacx.2024.100468. eCollection 2024 Jun.
3
The practice of using repurposed medications as chemoprophylaxis for COVID-19 by healthcare workers in a tertiary hospital in Southern Nigeria.尼日利亚南部一家三级医院的医护人员将已上市药物重新用于 COVID-19 化学预防的做法。
Afr Health Sci. 2023 Sep;23(3):406-411. doi: 10.4314/ahs.v23i3.47.
4
The practice of using repurposed medications as chemoprophylaxis for COVID-19 by healthcare workers in a tertiary hospital in Southern Nigeria.在尼日利亚南部一家三级医院，医护人员将已上市药物重新用于 COVID-19 化学预防的做法。
Afr Health Sci. 2023 Jun;23(2):37-42. doi: 10.4314/ahs.v23i2.5.
5
Simultaneous LC-MS/MS method for the quantitation of Azithromycin, Hydroxychloroquine and its metabolites in SARS-CoV-2(-/ +) populations using dried blood spots.采用干血斑法同时 LC-MS/MS 定量检测 SARS-CoV-2(+/−)人群中的阿奇霉素、羟氯喹及其代谢物。
Sci Rep. 2023 Sep 30;13(1):16428. doi: 10.1038/s41598-023-43185-9.
6
Unit information prior for incorporating real-world evidence into randomized controlled trials.纳入真实世界证据的单位信息。
Stat Methods Med Res. 2023 Feb;32(2):229-241. doi: 10.1177/09622802221133555.
7
Hospital-Based Quasi-Experimental Study on Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Providers with Its Potential Side-Effects.关于医护人员使用羟氯喹进行新冠病毒病暴露前预防及其潜在副作用的基于医院的准实验研究
Life (Basel). 2022 Dec 7;12(12):2047. doi: 10.3390/life12122047.
8
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.羟氯喹/氯喹治疗 COVID-19 住院患者：一项个体参与者数据荟萃分析。
PLoS One. 2022 Sep 29;17(9):e0273526. doi: 10.1371/journal.pone.0273526. eCollection 2022.
9
Sports Participation and Anti-Epidemic: Empirical Evidence on the Influence of Regular Physical Activity on the COVID-19 Pandemic in Mainland China.运动参与与抗疫：中国内地定期体育锻炼对新冠疫情影响的实证证据。
Int J Environ Res Public Health. 2022 Aug 27;19(17):10689. doi: 10.3390/ijerph191710689.
10
Efficacy of polyherbal formulations for prevention of COVID-19 infection in high-risk subjects: A randomized open-label controlled clinical trial.多草药配方预防高危人群 COVID-19 感染的疗效：一项随机、开放标签、对照临床试验。
Phytother Res. 2022 Sep;36(9):3632-3643. doi: 10.1002/ptr.7531. Epub 2022 Jul 5.

本文引用的文献

1
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.羟氯喹在美国 COVID-19 住院患者中的使用效果。
Med. 2020 Dec 18;1(1):114-127.e3. doi: 10.1016/j.medj.2020.06.001. Epub 2020 Jun 5.
2
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
3
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
4
Combination prevention for COVID-19.2019冠状病毒病的联合预防措施
Science. 2020 May 8;368(6491):551. doi: 10.1126/science.abc5798.
5
Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020.2020 年 3 月，荷兰医护人员的早期症状与 SARS-CoV-2 检测阳性结果有很强的关联性和中等的预测价值。
Euro Surveill. 2020 Apr;25(16). doi: 10.2807/1560-7917.ES.2020.25.16.2000508.
6
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.一种口服生物利用度的广谱抗病毒药物可抑制人呼吸道上皮细胞培养中的 SARS-CoV-2 病毒和小鼠中的多种冠状病毒。
Sci Transl Med. 2020 Apr 29;12(541). doi: 10.1126/scitranslmed.abb5883. Epub 2020 Apr 6.
7
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.洛匹那韦疗法治疗严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒的系统评价——为新型冠状病毒病治疗方案提供参考。
J Med Virol. 2020 Jun;92(6):556-563. doi: 10.1002/jmv.25729. Epub 2020 Mar 12.
8
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
9
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.氯喹及其羟基类似物的再利用以应对21世纪的细菌、真菌和病毒感染。
Int J Antimicrob Agents. 2007 Oct;30(4):297-308. doi: 10.1016/j.ijantimicag.2007.05.015. Epub 2007 Jul 16.